The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H.
Right arrow Articles by Paul, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.
Right arrow Articles by Paul, W. E.

The Journal of Immunology, Vol 158, Issue 11 5112-5119, Copyright © 1997 by American Association of Immunologists

ARTICLES

NK1.1+ CD4+ T cells lose NK1.1 expression upon in vitro activation

H Chen, H Huang and WE Paul
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

NK1.1+ CD4+ T cells produce IL-4 promptly in vivo upon injection of anti-CD3 and may play a role in initiating Th2 cell-mediated immunity. To characterize their in vitro activation properties, NK1.1+ CD4+ T cells were obtained in high purity from spleens of normal C57BL/6 mice, where they represent 2 to 5% of CD4+ T cells, or from MHC-class II I-Ab gene knockout mice, where they constitute 42% of CD4+ T cells. Activation of NK1.1+ CD4+ T cells from either source with plate-bound anti-CD3 resulted in loss of expression of NK1.1 as determined both by flow cytometric analysis and by reverse transcriptase-PCR analysis. A portion of these cells also lost CD4 expression. Both the CD4+ and CD4- activated cells retained the over-representation of V beta8 and V alpha14 chains and expressed the intermediate levels of the TCR-CD3 complex that is characteristic of resting NK1.1+ CD4+ T cells. The anti- NK1.1 mAb used for cell sorting was not the cause of NK1.1 or CD4 disappearance, since the sorted cells remain both NK1.1+ and CD4+ when cultured in the absence of anti-CD3 or in the presence of anti-CD3 and cyclosporin A. Furthermore, NK1.1+ CD4+ T cells that were not treated with anti-NK1.1 Ab also lost NK1.1 expression after activation. Populations of activated CD4+ and CD4- cells (derived from NK1.1+ CD4+ T cells) produced both IL-4 and IFN-gamma upon restimulation with plate- bound anti-CD3.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
M. Emoto, I. Yoshizawa, Y. Emoto, M. Miamoto, R. Hurwitz, and S. H. E. Kaufmann
Rapid Development of a Gamma Interferon-Secreting Glycolipid/CD1d-Specific V{alpha}14+ NK1.1- T-Cell Subset after Bacterial Infection.
Infect. Immun., October 1, 2006; 74(10): 5903 - 5913.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
O. Zachariadis, J. P. Cassidy, J. Brady, and B. P. Mahon
{gamma}{delta} T Cells Regulate the Early Inflammatory Response to Bordetella pertussis Infection in the Murine Respiratory Tract
Infect. Immun., March 1, 2006; 74(3): 1837 - 1845.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. G. Pellicci, K. J. L. Hammond, J. Coquet, K. Kyparissoudis, A. G. Brooks, K. Kedzierska, R. Keating, S. Turner, S. Berzins, M. J. Smyth, et al.
DX5/CD49b-Positive T Cells Are Not Synonymous with CD1d-Dependent NKT Cells
J. Immunol., October 1, 2005; 175(7): 4416 - 4425.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Forestier, A. Molano, J. S. Im, Y. Dutronc, B. Diamond, A. Davidson, P. A. Illarionov, G. S. Besra, and S. A. Porcelli
Expansion and Hyperactivity of CD1d-Restricted NKT Cells during the Progression of Systemic Lupus Erythematosus in (New Zealand Black x New Zealand White)F1 Mice
J. Immunol., July 15, 2005; 175(2): 763 - 770.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. N. Ajuebor, A. I. Aspinall, F. Zhou, T. Le, Y. Yang, S. J. Urbanski, S. Sidobre, M. Kronenberg, C. M. Hogaboam, and M. G. Swain
Lack of Chemokine Receptor CCR5 Promotes Murine Fulminant Liver Failure by Preventing the Apoptosis of Activated CD1d-Restricted NKT Cells
J. Immunol., June 15, 2005; 174(12): 8027 - 8037.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z.-Y. Wang, H. Sato, S. Kusam, S. Sehra, L. M. Toney, and A. L. Dent
Regulation of IL-10 Gene Expression in Th2 Cells by Jun Proteins
J. Immunol., February 15, 2005; 174(4): 2098 - 2105.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. V. Parekh, A. K. Singh, M. T. Wilson, D. Olivares-Villagomez, J. S. Bezbradica, H. Inazawa, H. Ehara, T. Sakai, I. Serizawa, L. Wu, et al.
Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct {alpha}- and {beta}-Anomeric Glycolipids
J. Immunol., September 15, 2004; 173(6): 3693 - 3706.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Saito, A. Okumura, H. Watanabe, M. Asano, A. Ishida-Okawara, J. Sakagami, K. Sudo, Y. Hatano-Yokoe, J. S. Bezbradica, S. Joyce, et al.
Increase in Hepatic NKT Cells in Leukocyte Cell-Derived Chemotaxin 2-Deficient Mice Contributes to Severe Concanavalin A-Induced Hepatitis
J. Immunol., July 1, 2004; 173(1): 579 - 585.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Sun, Z. Tian, S. Kulkarni, and B. Gao
IL-6 Prevents T Cell-Mediated Hepatitis via Inhibition of NKT Cells in CD4+ T Cell- and STAT3-Dependent Manners
J. Immunol., May 1, 2004; 172(9): 5648 - 5655.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. J. Roberts, Y. Lin, P. M. Spence, L. Van Kaer, and R. R. Brutkiewicz
CD1d1-Dependent Control of the Magnitude of an Acute Antiviral Immune Response
J. Immunol., March 15, 2004; 172(6): 3454 - 3461.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Yang, A. Ueno, M. Bao, Z. Wang, J. S. Im, S. Porcelli, and J.-W. Yoon
Control of NKT Cell Differentiation by Tissue-Specific Microenvironments
J. Immunol., December 1, 2003; 171(11): 5913 - 5920.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Y. Crowe, A. P. Uldrich, K. Kyparissoudis, K. J. L. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M. J. Smyth, and D. I. Godfrey
Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells
J. Immunol., October 15, 2003; 171(8): 4020 - 4027.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J.-Q. Yang, V. Saxena, H. Xu, L. Van Kaer, C.-R. Wang, and R. R. Singh
Repeated {alpha}-Galactosylceramide Administration Results in Expansion of NK T Cells and Alleviates Inflammatory Dermatitis in MRL-lpr/lpr Mice
J. Immunol., October 15, 2003; 171(8): 4439 - 4446.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. T. Wilson, C. Johansson, D. Olivares-Villagomez, A. K. Singh, A. K. Stanic, C.-R. Wang, S. Joyce, M. J. Wick, and L. Van Kaer
The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion
PNAS, September 16, 2003; 100(19): 10913 - 10918.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Nakamura, K.-H. Sonoda, D. E. Faunce, J. Gumperz, T. Yamamura, S. Miyake, and J. Stein-Streilein
CD4+ NKT Cells, But Not Conventional CD4+ T Cells, Are Required to Generate Efferent CD8+ T Regulatory Cells Following Antigen Inoculation in an Immune-Privileged Site
J. Immunol., August 1, 2003; 171(3): 1266 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J.-M. Waldburger, S. Rossi, G. A. Hollander, H.-R. Rodewald, W. Reith, and H. Acha-Orbea
Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells
Blood, May 1, 2003; 101(9): 3550 - 3559.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
T. Yoshimoto, B. Min, T. Sugimoto, N. Hayashi, Y. Ishikawa, Y. Sasaki, H. Hata, K. Takeda, K. Okumura, L. Van Kaer, et al.
Nonredundant Roles for CD1d-restricted Natural Killer T Cells and Conventional CD4+ T Cells in the Induction of Immunoglobulin E Antibodies in Response to Interleukin 18 Treatment of Mice
J. Exp. Med., April 21, 2003; 197(8): 997 - 1005.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Chackerian, J. Alt, V. Perera, and S. M. Behar
Activation of NKT Cells Protects Mice from Tuberculosis
Infect. Immun., November 1, 2002; 70(11): 6302 - 6309.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. D. Gadola, N. Dulphy, M. Salio, and V. Cerundolo
V{alpha}24-J{alpha}Q-Independent, CD1d-Restricted Recognition of {alpha}-Galactosylceramide by Human CD4+ and CD8{alpha}{beta}+ T Lymphocytes
J. Immunol., June 1, 2002; 168(11): 5514 - 5520.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. A. Hobbs, S. Cho, T. J. Roberts, V. Sriram, J. Zhang, M. Xu, and R. R. Brutkiewicz
Selective Loss of Natural Killer T Cells by Apoptosis following Infection with Lymphocytic Choriomeningitis Virus
J. Virol., November 15, 2001; 75(22): 10746 - 10754.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Maeda, S. Lohwasser, T. Yamamura, and F. Takei
Regulation of NKT Cells by Ly49: Analysis of Primary NKT Cells and Generation of NKT Cell Line
J. Immunol., October 15, 2001; 167(8): 4180 - 4186.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Karnbach, M. R. Daws, E. C. Niemi, and M. C. Nakamura
Immune Rejection of a Large Sarcoma Following Cyclophosphamide and IL-12 Treatment Requires Both NK and NK T Cells and Is Associated with the Induction of a Novel NK T Cell Population
J. Immunol., September 1, 2001; 167(5): 2569 - 2576.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. J. L. Hammond, D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey
CD1d-Restricted NKT Cells: An Interstrain Comparison
J. Immunol., August 1, 2001; 167(3): 1164 - 1173.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Trobonjaca, F. Leithauser, P. Moller, H. Bluethmann, Y. Koezuka, H. R. MacDonald, and J. Reimann
MHC-II-Independent CD4+ T Cells Induce Colitis in Immunodeficient RAG-/- Hosts
J. Immunol., March 15, 2001; 166(6): 3804 - 3812.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Carnaud, J.-M. Gombert, O. Donnars, H.-J. Garchon, and A. Herbelin
Protection Against Diabetes and Improved NK/NKT Cell Performance in NOD.NK1.1 Mice Congenic at the NK Complex
J. Immunol., February 15, 2001; 166(4): 2404 - 2411.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Hameg, I. Apostolou, M. Leite-de-Moraes, J.-M. Gombert, C. Garcia, Y. Koezuka, J.-F. Bach, and A. Herbelin
A Subset of NKT Cells That Lacks the NK1.1 Marker, Expresses CD1d Molecules, and Autopresents the {alpha}-Galactosylceramide Antigen
J. Immunol., November 1, 2000; 165(9): 4917 - 4926.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Skold, N. N. Faizunnessa, C.-R. Wang, and S. Cardell
CD1d-Specific NK1.1+ T Cells with a Transgenic Variant TCR
J. Immunol., July 1, 2000; 165(1): 168 - 174.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Gays, M. Unnikrishnan, S. Shrestha, K. P. Fraser, A. R. Brown, C. M. G. Tristram, Z. M. A. Chrzanowska-Lightowlers, and C. G. Brooks
The Mouse Tumor Cell Lines EL4 and RMA Display Mosaic Expression of NK-Related and Certain Other Surface Molecules and Appear to Have a Common Origin
J. Immunol., May 15, 2000; 164(10): 5094 - 5102.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
K.-H. Sonoda, M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein
CD1-reactive Natural Killer T Cells Are Required for Development of Systemic Tolerance through an Immune-Privileged Site
J. Exp. Med., November 1, 1999; 190(9): 1215 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
K. Benlagha, A. Weiss, A. Beavis, L. Teyton, and A. Bendelac
In Vivo Identification of Glycolipid Antigen-specific T Cells Using Fluorescent CD1d Tetramers
J. Exp. Med., June 6, 1999; 191(11): 1895 - 1904.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. Moodycliffe, S. Maiti, and S. E. Ullrich
Splenic NK1.1-Negative, TCR{alpha}{beta} Intermediate CD4+ T Cells Exist in Naive NK1.1 Allelic Positive and Negative Mice, with the Capacity to Rapidly Secrete Large Amounts of IL-4 and IFN-{gamma} Upon Primary TCR Stimulation
J. Immunol., May 1, 1999; 162(9): 5156 - 5163.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
I-C. Ho, M. H. Kaplan, L. Jackson-Grusby, L. H. Glimcher, and M. J. Grusby
Marking IL-4-producing cells by knock-in of the IL-4 gene
Int. Immunol., February 1, 1999; 11(2): 243 - 247.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
L. Schofield, M. J. McConville, D. Hansen, A. S. Campbell, B. Fraser-Reid, M. J. Grusby, and S. D. Tachado
CD1d-Restricted Immunoglobulin G Formation to GPI-Anchored Antigens Mediated by NKT Cells
Science, January 8, 1999; 283(5399): 225 - 229.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
S. M. Behar, T. A. Podrebarac, C. J. Roy, C. R. Wang, and M. B. Brenner
Diverse TCRs Recognize Murine CD1
J. Immunol., January 1, 1999; 162(1): 161 - 167.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Burdin, L. Brossay, Y. Koezuka, S. T. Smiley, M. J. Grusby, M. Gui, M. Taniguchi, K. Hayakawa, and M. Kronenberg
Selective Ability of Mouse CD1 to Present Glycolipids: {alpha}-Galactosylceramide Specifically Stimulates V{alpha}14+ NK T Lymphocytes
J. Immunol., October 1, 1998; 161(7): 3271 - 3281.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Tamada, M. Harada, K. Abe, T. Li, and K. Nomoto
IL-4-Producing NK1.1+ T Cells Are Resistant to Glucocorticoid-Induced Apoptosis: Implications for the Th1/Th2 Balance
J. Immunol., August 1, 1998; 161(3): 1239 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
D. G. Pellicci, K. J.L. Hammond, A. P. Uldrich, A. G. Baxter, M. J. Smyth, and D. I. Godfrey
A Natural Killer T (NKT) Cell Developmental Pathway Involving a Thymus-dependent NK1.1-CD4+ CD1d-dependent Precursor Stage
J. Exp. Med., March 25, 2002; 195(7): 835 - 844.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.